Thales’s Friendly Hackers Unit Invents Metamodel to Detect AI-generated Deepfake Images
Artificial intelligence is the central theme of this year’s European Cyber Week from 19-21 November in Rennes, Brittany. In a challenge organised to coincide with the event by France's Defence Innovation Agency (AID), Thales teams have successfully developed a metamodel for detecting AI-generated images. As the use of AI technologies gains traction, and at a time when disinformation is becoming increasingly prevalent in the media and impacting every sector of the economy, the deepfake detection metamodel offers a way to combat image manipulation in a wide range of use cases, such as the fight against identity fraud.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120808818/en/
(c)Thales
AI-generated images are created using AI platforms such as Midjourney, Dall-E and Firefly. Some studies have predicted that within a few years the use of deepfakes for identity theft and fraud could cause huge financial losses. Gartner has estimated that around 20% of cyberattacks in 2023 likely included deepfake content as part of disinformation and manipulation campaigns. Their report1 highlights the growing use of deepfakes in financial fraud and advanced phishing attacks.
“Thales’s deepfake detection metamodel addresses the problem of identity fraud and morphing techniques,”2 said Christophe Meyer, Senior Expert in AI and CTO of cortAIx, Thales’s AI accelerator. “Aggregating multiple methods using neural networks, noise detection and spatial frequency analysis helps us better protect the growing number of solutions requiring biometric identity checks. This is a remarkable technological advance and a testament to the expertise of Thales’s AI researchers.”
The Thales metamodel uses machine learning techniques, decision trees and evaluations of the strengths and weaknesses of each model to analyse the authenticity of an image. It combines various models, including:
- The CLIP method (Contrastive Language-Image Pre-training) involves connecting image and text by learning common representations. To detect deepfakes, the CLIP method analyses images and compares them with their textual descriptions to identify inconsistencies and visual artefacts.
- The DNF (Diffusion Noise Feature) method uses current image-generation architectures (called diffusion models) to detect deepfakes. Diffusion models are based on an estimate of the amount of noise to be added to an image to cause a “hallucination”, which creates content out of nothing, and this estimate can be used in turn to detect whether an image has been generated by AI.
- The DCT (Discrete Cosine Transform) method of deepfake detection analyses the spatial frequencies of an image to spot hidden artefacts. By transforming an image from the spatial domain (pixels) to the frequency domain, DCT can detect subtle anomalies in the image structure, which occur when deepfakes are generated and are often invisible to the naked eye.
The Thales team behind the invention is part of cortAIx, the Group’s AI accelerator, which has over 600 AI researchers and engineers, 150 of whom are based at the Saclay research and technology cluster south of Paris and work on mission-critical systems. The Friendly Hackers team has developed a toolbox called BattleBox to help assess the robustness of AI-enabled systems against attacks designed to exploit the intrinsic vulnerabilities of different AI models (including Large Language Models), such as adversarial attacks and attempts to extract sensitive information. To counter these attacks, the team develops advanced countermeasures such as unlearning, federated learning, model watermarking and model hardening.
In 2023, Thales demonstrated its expertise during the CAID challenge (Conference on Artificial Intelligence for Defence) organised by the French defence procurement agency (DGA), which involved finding AI training data even after it had been deleted from the system to protect confidentiality.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies specialising in three business domains: Defence & Security, Aeronautics & Space and Cybersecurity & Digital Identity.
The Group develops products and solutions that help make the world safer, greener and more inclusive.
Thales invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as IA, cybersecurity, quantum technologies, cloud technologies and 6G.
Thales has 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.
PLEASE VISIT
Developing AI systems we can all trust | Thales Group
12023 Gartner Report on Emerging Cybersecurity Risks.
2Morphing involves gradually changing one face into another in successive stages by modifying visual features to create a realistic image combining elements of both faces. The final result looks like a mix of the two original appearances.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241120808818/en/
Contacts
Marion Bonnet
Thales PR Manager
Marion.bonnet@thalesgroup.com
+33660384892
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement20.11.2024 14:05:00 CET | Press Release
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120379204/en/ Bladder cancer remains a significant health challenge worldwide, with over 614,000 new cases and 220,600 deaths recorded in 2022. Novotech’s latest report provides a detailed examination of the evolving landscape in bladder cancer research, with a focus on clinical trial trends, emerging therapeutic strategies, and regional variations in patient outcomes. Key Highlights from the Report: Bladder Cancer Statistics: A thorough analysis of incidence and survival data, highlighting that Europe and
TreviPay Embeds Dynamic Trade Credit Application into B2B Buyer Onboarding Process20.11.2024 14:00:00 CET | Press Release
TreviPay, the most-trusted B2B payments and invoicing network, has expanded its order-to-cash (O2C) offering by enhancing the buyer onboarding experience through automation. With TreviPay’s proprietary Risk Management Platform, business buyers can now apply for trade credit through a dynamic self-serve application, making the onboarding experience easier, faster and more tailored. As the global B2B market continues to grow, sellers can leverage TreviPay’s automation technology to reduce manual reviews while also speeding up credit decisioning to near real-time. The dynamic application is localized for an expanded list of key geographies, including the U.S., Australia, Canada and the UK, to ensure country-specific business terminology, language and foreign regulatory requirements are addressed. As highlighted during the inaugural TreviPay Crossroads conference in October, merchants who optimize the O2C process improve the B2B payments experience and build long-term buyer loyalty. Seamle
Uniphore and Konecta Join Forces to Advance AI in Customer Experience and Digital Transformation20.11.2024 14:00:00 CET | Press Release
Uniphore, a global AI leader with the only end-to-end Enterprise AI architecture that delivers unmatched customer focused solutions, together with Konecta, a global leader in customer experience (CX) and digital services, today announced a strategic alliance that will create and accelerate true AI-powered value worldwide. This is a significant first in the evolution of Enterprise AI with two industry leaders coming together to deliver real ROI through scalable solutions across hundreds of large global customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120819767/en/ Global enterprises will benefit from the combined strengths of Uniphore’s enterprise-grade AI solutions and Konecta’s expertise in business transformation. By merging advanced AI with operational excellence, this collaboration is set to reshape customer service delivery, generating actionable insights that drive real value. Clients can expect improved RO
DentalMonitoring Software Major Update Includes FDA Validated AI-Driven Clinical Indications For Orthodontic Patients20.11.2024 11:20:00 CET | Press Release
DentalMonitoring, the leader in Artificial Intelligence (AI)-powered remote monitoring for orthodontics, has released a major software update introducing features and indications based on the company’s De Novo approval from the U.S. Food and Drug Administration (FDA) in May 2024. Used by orthodontists around the world to optimize clinical care, DentalMonitoring’s remote monitoring solution leverages advanced image processing algorithms to analyze intraoral remote scans during orthodontic treatment. Patients take these scans using the DentalMonitoring app on their smartphone with the ScanBoxpro phone holder. The AI-powered software supports practitioners with clinical indications to remotely detect, track, and monitor orthodontic treatment progress for enhanced real-time decision-making, supporting personalized treatment and optimizing scheduling. This makes treatment more convenient for patients and increases clinical control for providers. This press release features multimedia. View
Pulmonary Hypertension Awareness Month : Two European Studies Highlight the Urgency of Patients and Experts to Improve the Diagnosis and Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease20.11.2024 11:00:00 CET | Press Release
Within the month of awareness of pulmonary hypertension, two studies carried out in Europe have been published, highlighting the urgency of patients and doctors to improve the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease. PH is a condition characterised by elevated blood pressure in the pulmonary arteries (the arteries that carry blood from the heart to the lungs)2, whereas ILD are a group of disorders that cause scarring and inflammation of the lung tissue, leading to reduced lung function and difficulty in oxygen transfer2. When PH develops with ILD, it complicates the disease, making it more severe and harder to manage2. On the one hand, a qualitative research carried out by clinical experts, the Pulmonary Hypertension Association Europe (PHA Europe) and the European Pulmonary Fibrosis Federation (EU-PFF) representatives, ORPHA Strategy Consulting, and Ferrer, a B Corp-certified international pharmaceutical company, has highlighted for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom